Literature DB >> 12213613

Unidentified bright objects associated with features of neurofibromatosis 1.

Jacek Szudek1, J M Friedman.   

Abstract

Unidentified bright objects are commonly observed on magnetic resonance imaging in young neurofibromatosis 1 patients, but their clinical and pathologic significance is largely unknown. Diagnostic features of neurofibromatosis 1 include café-au-lait spots, intertriginous freckling, Lisch nodules, neurofibromas, bony lesions, and optic glioma. We investigated the relationship between unidentified bright objects and other features of neurofibromatosis 1. Data from the National Neurofibromatosis Foundation International Database included 523 neurofibromatosis 1 patients between 2 and 20 years of age who had cranial magnetic resonance imaging examinations. The presence or absence of unidentified bright objects, diagnostic features of neurofibromatosis 1, and central nervous system neoplasms was known in these patients. Logistic regressive models were used to measure associations between unidentified bright objects and the other features while controlling for age. The occurrence of unidentified bright objects was associated with the number of diagnostic features, but most significantly with central nervous system neoplasms other than optic gliomas [odds ratio (OR) = 9.0, 95% confidence interval (CI) = 1.2-70], optic gliomas (OR = 2.1, 95% CI = 1.2-3.6), subcutaneous neurofibromas (OR = 2.0, 95% CI = 1.3-3.1), and Lisch nodules (OR = 1.6, 95% CI = 1.1-2.3). These findings suggest a common causal mechanism between unidentified bright objects and these cardinal clinical features in children with neurofibromatosis 1.

Entities:  

Mesh:

Year:  2002        PMID: 12213613     DOI: 10.1016/s0887-8994(02)00403-4

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  Diffusion tensor imaging of neurofibromatosis bright objects in children with neurofibromatosis type 1.

Authors:  Gulhan Ertan; Elcin Zan; David M Yousem; Can Ceritoglu; Aylin Tekes; Andrea Poretti; Thierry A G M Huisman
Journal:  Neuroradiol J       Date:  2014-09-25

2.  Diffusion tensor MR imaging in neurofibromatosis type 1: expanding the knowledge of microstructural brain abnormalities.

Authors:  José R L Ferraz-Filho; Antônio J da Rocha; Marcos P Muniz; Antônio S Souza; Eny M Goloni-Bertollo; Erika C Pavarino-Bertelli
Journal:  Pediatr Radiol       Date:  2011-10-28

3.  A multi-institutional study of brainstem gliomas in children with neurofibromatosis type 1.

Authors:  Jasia Mahdi; Amish C Shah; Aimee Sato; Stephanie M Morris; Robert C McKinstry; Robert Listernick; Roger J Packer; Michael J Fisher; David H Gutmann
Journal:  Neurology       Date:  2017-03-22       Impact factor: 9.910

4.  Clinical sensitivity and specificity of multiple T2-hyperintensities on brain magnetic resonance imaging in diagnosis of neurofibromatosis type 1 in children: diagnostic accuracy study.

Authors:  Zlatko Sabol; Biserka Resić; Romana Gjergja Juraski; Filip Sabol; Matilda Kovac Sizgorić; Kresimir Orsolić; David Ozretić; Dubravka Sepić-Grahovac
Journal:  Croat Med J       Date:  2011-08-15       Impact factor: 1.351

5.  Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?

Authors:  Claudia Santoro; Pia Bernardo; Antonietta Coppola; Umberto Pugliese; Mario Cirillo; Teresa Giugliano; Giulio Piluso; Giuseppe Cinalli; Salvatore Striano; Carmela Bravaccio; Silverio Perrotta
Journal:  Ital J Pediatr       Date:  2018-03-22       Impact factor: 2.638

6.  Cerebellar radiological abnormalities in children with neurofibromatosis type 1: part 1 - clinical and neuroimaging findings.

Authors:  Michael S Salman; Shakhawat Hossain; Lina Alqublan; Martin Bunge; Katya Rozovsky
Journal:  Cerebellum Ataxias       Date:  2018-11-01

7.  Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

Authors:  Christina Bergqvist; Amandine Servy; Laurence Valeyrie-Allanore; Salah Ferkal; Patrick Combemale; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2020-02-03       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.